- Previous: Apple CEO Gets Hotly Debated Liver Transplant
- Main
- Next: HCV Research and Development Company a Promising Investment
Trial Tackling Hepatitis C With New Drug
June 30, 2009
By enrolling Hepatitis C patients for whom treatment with combination therapy is not advised, Conatus Pharmaceuticals is testing a unique compound that inhibits the activity of matrix metalloproteinases.
Conatus Pharmaceuticals Initiates Second Phase-II Hepatitis Trial
24-June-2009
By Staff Reporter
CTS-1027 is an oral, small molecule compound that inhibits the activity of matrix metalloproteinases
Conatus Pharmaceuticals (Conatus) has initiated the second phase-II clinical trial with a drug candidate, for the treatment of liver disease associated with Hepatitis C Virus (HCV) infection. The trial will enroll patients for whom treatment with approved standard of care treatments is not currently advised.
CTS-1027 is an oral, small molecule compound that inhibits the activity of key members of a class of protease enzymes, the matrix metalloproteinases or MMPs. CTS-1027 had previously shown to be effective in multiple preclinical models of inflammatory liver disease and HCV infection.
The clinical trial is a double-blind, placebo-controlled trial, testing an optimized dose of CTS-1027 alone or in combination with ribavirin. Dosing will last for up to 24 weeks. The company expects approximately 70 patients to be enrolled. The clinical trial will be conducted at 25 medical centers in the US.
Results from an earlier clinical trial in HCV patients who failed standard of care treatment, are expected to be reported later this year.
---
URL for Article Source:
http://www.pharmaceutical-business-review.com/news/conatus_pharmaceuticals_initiates_second_phaseii_hepatitis_trial_090624
Posted by Editors at June 30, 2009 3:25 PM
Site Topics
HCV Symptoms
You'll find links to a comprehensive symptoms list, as well as various studies and discussions about Hepatitis C symptoms.
Lab Tests
What they are and what they mean. Helps you interpret & understand all the various hepatitis lab tests likely to be encountered.
Hepatitis C Genotypes
Learn about Hepatitis C Genotypes and their variants.
Viral Load
Includes a convenient Viral Load chart, as well as a link to a detailed discussion on how to analyze and interpret viral load numbers.
What is...?
Learn more about various Hepatitis C related topics, including HCV, Ascites, Biopsies, and much more.
HCV Medicines
Numerous links to studies, info sheets, FAQs, and analysis of Ribavirin/Rebetron medicines.
Hepatitis C Doctors
A state-by-state and worldwide reference listing physicians who treat HCV, including an email link to submit your physician for inclusion.
Biopsy Info
A comprehensive resource of information relating to the liver biopsy.
Cirrhosis
Many discussions and analyses of cirrhosis, including causes, complications, pathology, symptoms, and much more.
Liver Cancer
Liver Cancer/Hepatocellular Carcinoma studies, info sheets, FAQs, and analysis.
Liver Disease Medicines
An exhaustive list of links to studies, info sheets, FAQs, and analysis of the various drugs used to treat liver disease.
Hep-Central Email List
Sign up to learn about advances and breakthroughs in Hepatitis C research, including information about medical and complementary treatments.
HCV Links
Convenient links to other sites external to Hepatitis-Central.
Mother/Child Transmission
Discussions of the special problems and precautions necessary involving mother to child transmission of Hepatitis C.
HCV Natural Remedies
A number of herbal products useful in the management of liver disease.
HCV Books
Recommended reading for those interested in hepatitis information.
Hepatitis C Forum
A Bulletin Board for discussions on hepatitis, treatments, etc.
Hepatitis C Activism
An easy way to get involved in urging our government to do more for Hepatitis C awareness and treatment research.
Advertisement
